Furthermore, it also shows a significant contribution to inflammatory disease conditions, including various cancers, through the activation of downstream signals such as PI3K/Akt/MAPK/ERK, resulting in the release of various inflammatory cytokines, including tumor necrosis factor alpha (TNF-α), and interleukins (IL-1β, IL-6, and IL-8). Here, AKT1 is linked to cancer.